Jeffrey C. Thompson

3.7k total citations · 1 hit paper
60 papers, 1.4k citations indexed

About

Jeffrey C. Thompson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jeffrey C. Thompson has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Jeffrey C. Thompson's work include Lung Cancer Treatments and Mutations (18 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Cancer Genomics and Diagnostics (14 papers). Jeffrey C. Thompson is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Cancer Genomics and Diagnostics (14 papers). Jeffrey C. Thompson collaborates with scholars based in United States, United Kingdom and Australia. Jeffrey C. Thompson's co-authors include Charu Aggarwal, Corey J. Langer, Joshua Bauml, Roger B. Cohen, Robert Broadwater, Stephen Bagley, Christine Ciunci, Erica L. Carpenter, Steven Μ. Albelda and Wei‐Ting Hwang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Jeffrey C. Thompson

57 papers receiving 1.4k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

2017 387 citations Stephen Bagley, Charu Aggarwal et al. Lung Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey C. Thompson United States	18	923	582	303	296	179	60	1.4k
Jantien A. Vogel Netherlands	14	743 0.8×	361 0.6×	230 0.8×	65 0.2×	84 0.5×	28	1.2k
Mika Matikainen Finland	23	183 0.2×	726 1.2×	189 0.6×	64 0.2×	508 2.8×	55	1.4k
C. Dilara Savci‐Heijink Netherlands	22	392 0.4×	500 0.9×	251 0.8×	148 0.5×	392 2.2×	57	1.5k
Antonella Vecchiato Italy	17	675 0.7×	321 0.6×	69 0.2×	135 0.5×	238 1.3×	63	1.1k
James Sun United States	22	1.0k 1.1×	381 0.7×	369 1.2×	132 0.4×	464 2.6×	82	1.8k
Chi‐Ju Yeh Taiwan	19	265 0.3×	315 0.5×	67 0.2×	43 0.1×	183 1.0×	78	982
Mohamed E. Salem United States	21	1.2k 1.3×	557 1.0×	463 1.5×	96 0.3×	392 2.2×	128	1.9k
Matthew J. Barth United States	18	548 0.6×	144 0.2×	61 0.2×	385 1.3×	304 1.7×	72	1.2k
Tony Tu United States	9	817 0.9×	352 0.6×	88 0.3×	792 2.7×	146 0.8×	9	1.5k
Shikai Wu China	18	461 0.5×	284 0.5×	186 0.6×	97 0.3×	159 0.9×	73	796

Countries citing papers authored by Jeffrey C. Thompson

Since Specialization

Citations

This map shows the geographic impact of Jeffrey C. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey C. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey C. Thompson more than expected).

Fields of papers citing papers by Jeffrey C. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey C. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey C. Thompson. The network helps show where Jeffrey C. Thompson may publish in the future.

Co-authorship network of co-authors of Jeffrey C. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey C. Thompson. A scholar is included among the top collaborators of Jeffrey C. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey C. Thompson. Jeffrey C. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thompson, Jeffrey C., Caitlin M. Tilsed, Christiana Davis, et al.. (2024). Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients. Cancers. 16(16). 2795–2795. 1 indexed citations

Thompson, Jeffrey C., Jarrod D. Predina, Evgeniy Eruslanov, et al.. (2024). Red blood cells function as reservoirs of tumor DNA. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(5). L646–L650. 2 indexed citations

Thompson, Jeffrey C., et al.. (2023). Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors. British Journal of Cancer. 129(12). 1893–1902. 35 indexed citations

Yegya‐Raman, Nikhil, Siqi Zhang, Roger B. Cohen, et al.. (2023). Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression. Clinical Lung Cancer. 25(1). 50–60.e6. 7 indexed citations

Aggarwal, Charu, Melina E. Marmarelis, Wei‐Ting Hwang, et al.. (2023). Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer. JCO Precision Oncology. 7(7). e2300191–e2300191. 22 indexed citations

Thompson, Jeffrey C., Erica L. Carpenter, Austin L. Chien, et al.. (2021). Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy. JCO Precision Oncology. 5(5). 510–524. 62 indexed citations

Yousefi, Bardia, Maya Galperin-Aizenberg, Leonid Roshkovan, et al.. (2021). Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography. Cancers. 13(23). 5985–5985. 11 indexed citations

Thompson, Jeffrey C., Christiana Davis, Wei‐Ting Hwang, et al.. (2020). Gene signature of antigen processing and presentation machinery (APM) as highly predictive of response to checkpoint blockade in lung cancer and melanoma.. Journal of Clinical Oncology. 38(15_suppl). 3121–3121. 1 indexed citations

Roshkovan, Leonid, Maya Galperin-Aizenberg, Rosita M. Shah, et al.. (2020). The Role of Imaging in the Management of Suspected or Known COVID-19 Pneumonia: A Multidisciplinary Perspective. Annals of the American Thoracic Society. 2 indexed citations

10.

Kargl, Julia, Xiaodong Zhu, Huajia Zhang, et al.. (2019). Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC. JCI Insight. 4(24). 127 indexed citations

11.

Klampatsa, Astero, Shaun O’Brien, Jeffrey C. Thompson, et al.. (2019). Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes. OncoImmunology. 8(9). e1638211–e1638211. 34 indexed citations

12.

O’Brien, Shaun, Astero Klampatsa, Jeffrey C. Thompson, et al.. (2019). Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer. Cancer Immunology Research. 7(6). 896–909. 67 indexed citations

13.

Aggarwal, Charu, Jeffrey C. Thompson, Austin L. Chien, et al.. (2019). MA25.04 Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Outcomes After Pembrolizumab Based First Line Therapy in Metastatic NSCLC. Journal of Thoracic Oncology. 14(10). S352–S352. 4 indexed citations

14.

Marmarelis, Melina E., Erin M. Bange, Stephen Bagley, et al.. (2018). P1.01-64 Impact of STK11 Co-Mutation on Outcomes Following Immunotherapy Among Patients with TP53 and KRAS Mutated Stage IV NSCLC. Journal of Thoracic Oncology. 13(10). S486–S486. 2 indexed citations

15.

Thompson, Jeffrey C., Ryan Fan, Taylor A. Black, et al.. (2018). Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients. Lung Cancer. 127. 25–33. 12 indexed citations

16.

Aggarwal, Charu, Christiana Davis, Rosemarie Mick, et al.. (2018). Influence of TP53 Mutation on Survival in Patients With Advanced EGFR-Mutant Non–Small-Cell Lung Cancer. JCO Precision Oncology. 2018(2). 1–29. 64 indexed citations

17.

Thompson, Jeffrey C., Gordon H. Yu, Anil Vachani, et al.. (2013). Use of Circulating Tumor Cell Technology (CELLSEARCH) for the Diagnosis of Malignant Pleural Effusions. Annals of the American Thoracic Society. 10(6). 582–589. 19 indexed citations

18.

Broadwater, Robert, Jeffrey C. Thompson, & Thomas E. McDermott. (2002). Pointers and linked lists in electric power distribution circuit analysis. 16–21. 10 indexed citations

19.

Thompson, Jeffrey C., et al.. (2002). DEWorkstation: a comprehensive distribution modeling tool. 7–12.

20.

Thompson, Jeffrey C., et al.. (1995). Distribution engineering tool features a flexible framework. IEEE Computer Applications in Power. 8(3). 21–24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact